TONX
TON Strategy Co. NASDAQ Listed Nov 19, 2014$2.56
+5.35%
vs $2.43
Mkt Cap $642.8M
52w Low $1.80
3.7% of range
52w High $22.45
50d MA $3.11
200d MA $3.36
P/E (TTM)
-0.7x
EV/EBITDA
—
P/B
1.6x
Debt/Equity
0.0x
ROE
-36.5%
P/FCF
-30.8x
RSI (14)
37.40
ATR (14)
$0.32
Beta
0.49
50d MA
$3.11
200d MA
$3.36
Avg Volume
372.5K
The first NASDAQ‑listed publicly traded treasury for Toncoin ($TON), the native cryptocurrency of The Open Network (TON). The company accumulates and stakes $TON to build a long-term treasury, offering regulated market exposure to TON through structured capital deployment and staking rewards.
3024 Sierra Juniper Court · Las Vegas, NV 89138 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 12, 2026 | BMO | — | — | — | 3.33 | -6.9% | +4.2% | +8.1% | -4.5% | +2.5% | -8.2% | — |
| Mar 24, 2026 | AMC | -1.77 | -2.20 | -24.3% | 2.81 | +2.1% | +5.0% | -8.8% | -9.7% | +0.8% | +0.8% | — |
| Nov 12, 2025 | AMC | -1.90 | -1.00 | +47.4% | 3.60 | +1.4% | -3.1% | -5.2% | -4.5% | -2.5% | -7.1% | — |
| Aug 6, 2025 | AMC | -2.04 | -1.79 | +12.3% | 19.65 | +0.3% | +0.6% | -15.0% | -5.4% | +6.6% | +1.5% | — |
| May 13, 2025 | AMC | -3.14 | -2.51 | +20.1% | 6.14 | -5.5% | -9.3% | +1.8% | +12.3% | -0.8% | +6.6% | — |
| Mar 25, 2025 | AMC | -2.52 | -2.20 | +12.7% | 5.47 | -2.9% | -2.6% | -6.4% | -1.4% | -5.1% | +4.3% | — |
| Nov 5, 2024 | AMC | -4.00 | -3.97 | +0.8% | 10.21 | +0.1% | -4.0% | +0.1% | -0.3% | +0.1% | -4.8% | — |
| Aug 14, 2024 | AMC | -3.00 | -4.00 | -33.3% | 14.42 | -9.8% | -4.3% | -2.8% | +5.2% | -1.4% | +13.4% | — |
| May 10, 2024 | AMC | -0.12 | -22.00 | -9999.0% | 26.38 | +1.1% | +9.2% | -3.1% | -1.8% | +12.8% | -7.2% | — |
| Apr 1, 2024 | AMC | -0.16 | -0.22 | -37.5% | 52.76 | -2.7% | +0.3% | -3.3% | -1.8% | -5.1% | -13.8% | — |
| Nov 14, 2023 | AMC | -0.60 | -130.00 | -9999.0% | 45.56 | -0.7% | -6.0% | +0.7% | -0.4% | -1.3% | -5.7% | — |
| Aug 14, 2023 | AMC | -38.00 | -188.00 | -394.7% | 220.00 | -2.7% | -2.7% | -1.9% | -6.7% | -0.5% | -5.7% | — |
| May 22, 2023 | AMC | -1.20 | -318.00 | -9999.0% | 336.00 | -0.6% | -5.4% | -3.8% | +1.3% | -0.6% | -3.9% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 30 | Ascendiant Capital | Maintains | Buy → Buy | — | $6.50 | $6.61 | +1.7% | +24.5% | -6.4% | +3.6% | +8.0% | +2.7% |
| Apr 21 | Ascendiant Capital | Maintains | Buy → Buy | — | $4.20 | $4.20 | +0.0% | +3.6% | +0.9% | +3.4% | -2.9% | +9.3% |
| Nov 11 | Ascendiant Capital | Maintains | Buy → Buy | — | $9.78 | $9.68 | -1.0% | +0.1% | -4.8% | -11.3% | -10.5% | -12.2% |
| Jun 29 | Ascendiant Capital | Maintains | Buy → Buy | — | $10560.00 | $12735.20 | +20.6% | +17.4% | +32.3% | -6.8% | -4.7% | +3.3% |
| Aug 20 | Alliance Global Partners | Maintains | Buy → Buy | — | $10320.00 | $11040.00 | +7.0% | -6.2% | -5.0% | -2.6% | +0.4% | +2.7% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| May 15, 2026 | Marbach MaryOff | General Counsel/Corp Secretary | Buy | 1,600 | $3.52 | $6K | 1,600 | -8.17% | +6.20% |
| May 14, 2026 | Wilson Kevin MarkOff | Chief Executive Officer | Buy | 8,020 | $3.66 | $29K | 8,020 | -8.17% | +6.20% |
| May 14, 2026 | Sohn EvanDir | — | Buy | 2,770 | $3.58 | $10K | 5,399 | -8.17% | +6.20% |
| May 14, 2026 | Sohn EvanDir | — | Buy | 2,770 | $3.58 | $10K | 5,399 | -8.17% | +6.20% |
| May 14, 2026 | Wilson Kevin MarkOff | Chief Executive Officer | Buy | 8,020 | $3.66 | $29K | 8,020 | +2.51% | +13.11% |
| May 14, 2026 | Olsen Sarah JosephineOff | CFO & COO | Buy | 7,440 | $3.62 | $27K | 7,440 | +2.51% | +13.11% |
8-K
TON Strategy Co. -- 8-K Filing
Jun 23
8-K
TON Strategy Co. -- 8-K Filing
Jun 12
8-K · 2.02
!! High
TON Strategy Co. -- 8-K 2.02: Earnings Results
May 12
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
The appointment of a new CEO at Tonix Pharmaceuticals signals a potential strategic shift that could affect drug development priorities and investor confidence, making it critical to evaluate the new leader's experience in biotech.
Apr 16
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
TONX's CFO departure effective April 2026 signals potential management instability and may indicate internal disagreements or strategic shifts, warranting investor scrutiny of leadership continuity plans.
Apr 2
8-K
Unknown — 8-K Filing
TON Strategy's full-year 2025 results and Toncoin treasury operations update will reveal whether its digital asset holding strategy generated sufficient returns to justify the stock's valuation amid cryptocurrency volatility.
Mar 31
8-K · 8.01
!! High
Unknown — 8-K 8.01: Material Event / Announcement
Tonix investors should note the filing establishes a strict April deadline for shareholder proposals at the 2026 annual meeting; missing it means exclusion from proxy materials and potential inability to raise concerns.
Mar 26
8-K · 5.02
!!! Very High
TON Strategy Company -- 8-K 5.02: Executive Change
TON Strategy Company appointed and simultaneously resigned director Rory J. Cutaia effective February 27, 2026, suggesting a leadership transition that warrants monitoring for potential strategic shifts.
Mar 2
Valuation
Market Cap
$642.8M
Enterprise Value
$603.4M
P/E (TTM)
-0.71x
Forward P/E
—
PEG Ratio
-0.00x
P/B
1.58x
P/S
38.43x
P/FCF
-30.82x
EV/EBITDA
—
Shares Out
251.1M
Financials (TTM)
Revenue
$16.7M
Net Income
-$237.0M
EBITDA
-$149.0M
Free Cash Flow
-$20.9M
Op Cash Flow
-$20.8M
EPS Basic
$-5.96
EPS Diluted
$-3.61
EPS Forward
$-5.27
Gross Margin
71.0%
Op Margin
-206.5%
Net Margin
—
Balance Sheet
Total Assets
$411.2M
Total Liab.
$4.8M
Total Equity
$406.3M
Cash
$39.5M
LT Debt
$80K
Book Value/Sh
$1.62
Debt/Equity
0.00x
Current Ratio
9.23
Quick Ratio
9.23
Returns & Growth
ROE
-36.5%
ROA
-36.1%
ROIC
-8.2%
Rev Growth YoY
+1327.8%
EPS Growth YoY
-34152.9%
Price Returns
2W
+11.2%
1M
+96.1%
3M
+105.2%
6M
+16.7%
12M
-50.8%
Technicals
52W High
$22.45
52W Low
$1.80
50d MA
$3.11
200d MA
$3.36
RSI (14)
37.40
ATR (14)
$0.32
Beta
0.49
Avg Volume
373K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
—
High
—
Low
—
Median
—
Data updated apr 27, 2026 5:16am
· Source: financialmodelingprep.com